ConductScience.org, home

Paper2017529

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

Elia J and 3 others. Psychiatry Res, 1991. Cited by 209 papers, by iCite.

Cite this record

ConductScience Library. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Papers, record 2017529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2017529

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?
PubMed
Journal
Psychiatry Res
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
209
iCite
Relative citation ratio, by iCite
9.54
iCite
Revised in PubMed
2019-08-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Elia JJ
2Borcherding BGB G
3Rapoport JLJ L
4Keysor CSC S

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Attention Deficit Disorder with HyperactivityMajor topic
DextroamphetamineMajor topic
MethylphenidateMajor topic
Analysis of Variance
Child
Day Care, Medical
Double-Blind Method
Humans
Male
Placebos
Research Design

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 209 citations.

PMIDTitleJournalYearIn PapersSource
42415397A Randomised Open-Label Comparison of Dexamphetamine and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD): Symptom Response, Adherence and Weight Impact Over 12 Months.J Paediatr Child Health2026https://conductscience.org/library/papers/42415397PubMed
36971690Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev2023https://conductscience.org/library/papers/36971690PubMed
36226261Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.Front Hum Neurosci2022https://conductscience.org/library/papers/36226261PubMed
35201607Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/35201607PubMed
33928056Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study.Scand J Child Adolesc Psychiatr Psychol2021https://conductscience.org/library/papers/33928056PubMed
33495438Altered dopaminergic firing pattern and novelty response underlie ADHD-like behavior of SorCS2-deficient mice.Transl Psychiatry2021https://conductscience.org/library/papers/33495438PubMed
32794136Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?CNS Drugs2020https://conductscience.org/library/papers/32794136PubMed
31455722Genetic Signatures of Drug Response Variability in Drosophila melanogaster.Genetics2019https://conductscience.org/library/papers/31455722PubMed
31122010Effect of omega-3 plus methylphenidate as an alternative therapy to reduce attention deficit-hyperactivity disorder in children.Korean J Pediatr2019https://conductscience.org/library/papers/31122010PubMed
27520752Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective.CNS Drugs1997https://conductscience.org/library/papers/27520752PubMed
27460004Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.BMC Psychiatry2016https://conductscience.org/library/papers/27460004PubMed
27453079Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.J Am Acad Child Adolesc Psychiatry2016https://conductscience.org/library/papers/27453079PubMed
26844979Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/26844979PubMed
26599576Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26599576PubMed
26587055Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway.Child Adolesc Psychiatry Ment Health2015https://conductscience.org/library/papers/26587055PubMed
25378930Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial.Neuropsychiatr Dis Treat2014https://conductscience.org/library/papers/25378930PubMed
24813374Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.J Child Adolesc Psychopharmacol2014https://conductscience.org/library/papers/24813374PubMed
24666268Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.J Child Adolesc Psychopharmacol2014https://conductscience.org/library/papers/24666268PubMed
23681505Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.Adv Ther2013https://conductscience.org/library/papers/23681505PubMed
23659360Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.J Child Adolesc Psychopharmacol2013https://conductscience.org/library/papers/23659360PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2017529

GET https://conductscience.org/api/papers/v1/2017529/cited_by?page=2